This company has been marked as potentially delisted and may not be actively trading. NYSE:BDR Blonder Tongue Laboratories (BDR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Blonder Tongue Laboratories Stock (NYSE:BDR) 30 days 90 days 365 days Advanced Chart Get BDR alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume190,300 shsAverage Volume364,033 shsMarket Capitalization$4.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBlonder Tongue Laboratories, Inc. operates as a technology development and manufacturing company, which engages in delivering television signal encoding, transcoding, digital transport, and broadband product solutions for applications. It also offers system operators and integrators serving the cable, broadcast, satellite, institutional, and professional video markets with solutions for the provision of content contribution, distribution, and video delivery to homes and businesses. The company was founded by Ben H. Tongue and Isaac S. Blonder in 1950 and is headquartered in Old Bridge, NJ.Read More… Receive BDR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Blonder Tongue Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address BDR Stock News HeadlinesN-able Is a Champion in Canalys Managed BDR Leadership Matrix for Second Consecutive YearMarch 11, 2025 | businesswire.comAbbott Laboratories (ABT)April 23, 2024 | finance.yahoo.comTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is about to announce could change the AI market once again. Experts already predict the total addressable market could climb past $20 trillion. But Sykes believes most investors have missed what’s coming next. He’s tracking a new shift — and says the biggest gains are still ahead.April 30, 2025 | Timothy Sykes (Ad)‘Mother Tongue’ offers a fascinating look at how we talk about womenSeptember 2, 2023 | washingtonpost.comSee More Headlines BDR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Blonder Tongue Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Blonder Tongue Laboratories investors own include Titan Pharmaceuticals (TTNP) and Yunhong CTI (CTIB). Industry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Telecommunications Equipment Sub-IndustryN/A Current SymbolNYSE:BDR CIKN/A WebN/A Phone(732) 679-4000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares13,326,000Free FloatN/AMarket Cap$4.06 million OptionableNot Optionable BetaN/A 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NYSE:BDR) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored#1 AI play of the decade…? (The answer will shock you)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blonder Tongue Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Blonder Tongue Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.